pmc logo image
Logo of iaiInfect Immun SubscriptionsInfect Immun Web Site

Formats:

Infect Immun. 1990 November; 58(11): 3779–3787.
PMCID: PMC313728
Streptococcus pyogenes clinical isolates and lipoteichoic acid.
O Leon and C Panos
Department of Microbiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
Abstract
Minimally subcultured clinical isolates of virulent nephritogenic and nonnephritogenic Streptococcus pyogenes of the same serotype showed major differences in lipoteichoic acid (LTA) production, secretion, and structure. These were related to changes in coccal adherence to and destruction of growing human skin cell monolayers in vitro. A possible relationship between cellular LTA content and group A streptococcal surface hydrophobicity was also investigated. Nephritogenic S. pyogenes M18 produced twice as much total (i.e., cellular and secretory) LTA as did the virulent, serologically identical, but nonnephritogenic isolate. Also, the LTAs from these organisms differed markedly. The polyglycerol phosphate chain of LTA from the nephritogenic isolate was longer (1.6 times) than was that from the nonnephritogenic isolate. Likewise, both LTAs indicated the presence of alanine and the absence of glucose. Amino sugars were found in LTA from only nephritogenic S. pyogenes. Teichoic acid, as a cellular component or secretory product, was not detected. The adherence of two different nephritogenic group A streptococcal serotypes (M18 and M2) exceeded that of the serologically identical but nonnephritogenic isolates (by about five times), indicating a correlation between virulent strains causing acute glomerulonephritis and adherence to human skin cell monolayers. Likewise, LTA from nephritogenic S. pyogenes M18 was more cytotoxic (1.5 times) than was that from the nonnephritogenic isolate for human skin cells, as determined by protein release. This difference was not perceptible by the more sensitive dye exclusion method (i.e., requiring less LTA), which emphasizes changes in host cell morphology and death. Also, the secretion of LTA by only virulent nephritogenic S. pyogenes M18 was exacerbated by penicillin (a maximum of four times). Finally, while the adherence of nephritogenic S. pyogenes M18 decreased markedly after continued subculturing in vitro, the surface hydrophobicity did not.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Alkan ML, Beachey EH. Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J Clin Invest. 1978 Mar;61(3):671–677. [PubMed]
  • Beachey EH. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis. 1981 Mar;143(3):325–345. [PubMed]
  • Courtney HS, Simpson WA, Beachey EH. Relationship of critical micelle concentrations of bacterial lipoteichoic acids to biological activities. Infect Immun. 1986 Feb;51(2):414–418. [PubMed]
  • DeVuono J, Panos C. Effect of L-form Streptococcus pyogenes and of lipoteichoic acid on human cells in tissue culture. Infect Immun. 1978 Oct;22(1):255–265. [PubMed]
  • Ganguly CL, Dale JB, Courtney HS, Beachey EH. Tyrosine phosphorylation of a 94-kDa protein of human fibroblasts stimulated by streptococcal lipoteichoic acid. J Biol Chem. 1985 Oct 25;260(24):13342–13346. [PubMed]
  • Gaworzewska E, Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect. 1988 Apr;100(2):257–269. [PubMed]
  • Goldschmidt JC, Jr, Panos C. Teichoic acids of Streptococcus agalactiae: chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture. Infect Immun. 1984 Feb;43(2):670–677. [PubMed]
  • Gutmann L, Tomasz A. Penicillin-resistant and penicillin-tolerant mutants of group A Streptococci. Antimicrob Agents Chemother. 1982 Jul;22(1):128–136. [PubMed]
  • Harrop PJ, O'Grady RL, Knox KW, Wicken AJ. Stimulation of lysosomal enzyme release from macrophages by lipoteichoic acid. J Periodontal Res. 1980 Sep;15(5):492–501. [PubMed]
  • Hausmann E, Lüderitz O, Knox K, Weinfeld N. Structural requirements for bone resorption by endotoxin and lipoteichoic acid. J Dent Res. 1975 Jun;54(SPEC):B94–B99. [PubMed]
  • Horne D, Hakenbeck R, Tomasz A. Secretion of lipids induced by inhibition of peptidoglycan synthesis in streptococci. J Bacteriol. 1977 Nov;132(2):704–717. [PubMed]
  • Leon O, Panos C. Cytotoxicity and inhibition of normal collagen synthesis in mouse fibroblasts by lipoteichoic acid from Streptococcus pyogenes type 12. Infect Immun. 1983 May;40(2):785–794. [PubMed]
  • Leon O, Panos C. Effect of streptococcal lipoteichoic acid on prolyl hydroxylase activity as related to collagen formation in mouse fibroblast monolayers. Infect Immun. 1985 Dec;50(3):745–752. [PubMed]
  • Leon O, Panos C. An electron microscope study of kidney basement membrane changes in the mouse by lipoteichoic acid from Streptococcus pyogenes. Can J Microbiol. 1987 Aug;33(8):709–717. [PubMed]
  • Matsuno T, Slade HD. Composition and properties of a group A streptococcal teichoic acid. J Bacteriol. 1970 Jun;102(3):747–752. [PubMed]
  • Miller GA, Urban J, Jackson RW. Effects of a streptococcal lipoteichoic acid on host responses in mice. Infect Immun. 1976 May;13(5):1408–1417. [PubMed]
  • Miyazaki S, Leon O, Panos C. Adherence of Streptococcus agalactiae to synchronously growing human cell monolayers without lipoteichoic acid involvement. Infect Immun. 1988 Feb;56(2):505–512. [PubMed]
  • Nealon TJ, Beachey EH, Courtney HS, Simpson WA. Release of fibronectin-lipoteichoic acid complexes from group A streptococci with penicillin. Infect Immun. 1986 Feb;51(2):529–535. [PubMed]
  • Nealon TJ, Mattingly SJ. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease. Infect Immun. 1983 Mar;39(3):1243–1251. [PubMed]
  • Nealon TJ, Mattingly SJ. Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells. Infect Immun. 1984 Feb;43(2):523–530. [PubMed]
  • Nealon TJ, Mattingly SJ. Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci. Infect Immun. 1985 Oct;50(1):107–115. [PubMed]
  • Ne'eman N, Ginsburg I. Red cell-sensitizing antigen of group A streptococci. II. Immunological and immunopathological properties. Isr J Med Sci. 1972 Nov;8(11):1807–1816. [PubMed]
  • Ofek I, Beachey EH, Jefferson W, Campbell GL. Cell membrane-binding properties of group A streptococcal lipoteichoic acid. J Exp Med. 1975 May 1;141(5):990–1003. [PubMed]
  • Rogers AH, Pilowsky K, Zilm PS. The effect of growth rate on the adhesion of the oral bacteria Streptococcus mutans and Streptococcus milleri. Arch Oral Biol. 1984;29(2):147–150. [PubMed]
  • Silvestri LJ, Knox KW, Wicken AJ, Hoffmann EM. Inhibition of complement-mediated lysis of sheep erythrocytes by cell-free preparations from Streptococcus mutans BHT. J Immunol. 1979 Jan;122(1):54–60. [PubMed]
  • Simpson WA, Dale JB, Beachey EH. Cytotoxicity of the glycolipid region of streptococcal lipoteichoic acid for cultures of human heart cells. J Lab Clin Med. 1982 Jan;99(1):118–126. [PubMed]
  • Simpson WA, Ofek I, Beachey EH. Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin. J Biol Chem. 1980 Jul 10;255(13):6092–6097. [PubMed]
  • Slabyj BM, Panos C. Teichoic acid of a stabilized L-form of Streptococcus pyogenes. J Bacteriol. 1973 Jun;114(3):934–942. [PubMed]
  • Slabyj BM, Panos C. Membrane lipoteichoic acid of Streptococcus pyogenes and its stabilized L-form and the effect of two antibiotics upon its cellular content. J Bacteriol. 1976 Aug;127(2):855–862. [PubMed]
  • Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989 Jul 6;321(1):1–7. [PubMed]
  • Tomlinson K, Leon O, Panos C. Morphological changes and pathology of mouse glomeruli infected with a streptococcal L-form or exposed to lipoteichoic acid. Infect Immun. 1983 Dec;42(3):1144–1151. [PubMed]
  • Treser G, Semar M, McVicar M, Franklin M, Ty A, Sagel I, Lange K. Antigenic streptococcal components in acute glomerulonephritis. Science. 1969 Feb 14;163(868):676–677. [PubMed]
  • Veasy LG, Wiedmeier SE, Orsmond GS, Ruttenberg HD, Boucek MM, Roth SJ, Tait VF, Thompson JA, Daly JA, Kaplan EL, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med. 1987 Feb 19;316(8):421–427. [PubMed]
  • Wald ER, Dashefsky B, Feidt C, Chiponis D, Byers C. Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics. 1987 Sep;80(3):371–374. [PubMed]
  • Waltersdorff RL, Fiedel BA, Jackson RW. Induction of nephrocalcinosis in rabbit kidneys after long-term exposure to a streptococcal teichoic acid. Infect Immun. 1977 Sep;17(3):665–667. [PubMed]